DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Miragen Therapeutics Q4 EPS $(0.31) Misses $(0.25) Estimate

Miragen Therapeutics (NASDAQ:MGEN) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.25) by 24 percent. This is a 6.06 percent increase over losses of $(0.33) per share

Benzinga · 03/11/2020 20:09

Miragen Therapeutics (NASDAQ:MGEN) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.25) by 24 percent. This is a 6.06 percent increase over losses of $(0.33) per share from the same period last year.